Posted by Michael Wonder on 03 Jul 2024
The rare paediatric disease voucher program creates new treatments. I have new data to prove it.
2 July 2024 - The FDA’s rare paediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations since 2012, is doomed to disappear unless Congress reauthorises it before the end of September.
Some lawmakers have downplayed its impressive track record based on unfounded allegations. I have data showing it works.
